84. Alpha 1 Antitrypsin Protein & Gene Therapies for the Treatment of Lupus in Animal Models

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)32893-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Philanthropy and Advocacy–Led Development of Gene Therapies and Drugs for Alpha-1 Antitrypsin Deficiency

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2015English

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha 1-Antitrypsin-Labor Und Alpha 1-Antitrypsin-Register

Pneumologie
MedicinePulmonaryRespiratory Medicine
2004English

Orphan Designation: Alpha-1 Antitrypsin (Inhalation Use), Treatment of Emphysema Secondary to Congenital Alpha-1-Antitrypsin Deficiency

Case Medical Research
2019English

Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2015English

Gene Targeted Therapeutics for Liver Disease in Alpha-1 Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha-1 Antitrypsin Blood Levels as Indicator for the Efficacy of Cancer Treatment

World Journal of Oncology
Cancer ResearchOncology
2013English

Alpha-1-Antitrypsin Deficiency

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy